(Q34301513)

1 August 2017

Open-label, randomized comparison of itraconazole versus caspofungin for prophylaxis in patients with hematologic malignancies (English)

1 reference

1 August 2017

8

Stefan Faderl

1 reference

1 August 2017

7

Srdan Verstovsek

1 reference

1 August 2017

5

Jorge Cortes

1 reference

1 August 2017

6

Susan O'brien

1 reference

1 August 2017

Luis L Ostrosky-Zeichner

4

object named as

Luis Ostrosky-Zeichner

1 reference

1 August 2017

14

Elihu H Estey

1 reference

1 August 2017

3

Francis J Giles

1 reference

1 August 2017

1

Gloria N Mattiuzzi

1 reference

1 August 2017

10

Issam I Raad

1 reference

1 August 2017

Gladys Alvarado

2

1 reference

1 August 2017

Xian Zhou

9

1 reference

1 August 2017

B Nebiyou Bekele

11

1 reference

1 August 2017

G J Leitz

12

1 reference

1 August 2017

Ivonne Lopez-Roman

13

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

Antimicrobial Agents and Chemotherapy

1 August 2017

1 reference

1 August 2017

50

1 reference

1 August 2017

1

1 reference

1 August 2017

143-147

1 reference

Amphotericin B lipid complex as prophylaxis of invasive fungal infections in patients with acute myelogenous leukemia and myelodysplastic syndrome undergoing induction chemotherapy

1 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Echinocandin antifungal drugs

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Antifungal susceptibility survey of 2,000 bloodstream Candida isolates in the United States.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Liposomal amphotericin B versus the combination of fluconazole and itraconazole as prophylaxis for invasive fungal infections during induction chemotherapy for patients with acute myelogenous leukemia and myelodysplastic syndrome

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Safety and tolerability of caspofungin acetate in the treatment of fungal infections

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Defining opportunistic invasive fungal infections in immunocompromised patients with cancer and hematopoietic stem cell transplants: an international consensus.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Using full probability models to compute probabilities of actual interest to decision makers

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Comparison of In vitro activities of the new triazole SCH56592 and the echinocandins MK-0991 (L-743,872) and LY303366 against opportunistic filamentous and dimorphic fungi and yeasts

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

In vitro activity of a new echinocandin, LY303366, compared with those of amphotericin B and fluconazole against clinical yeast isolates

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Sequential Treatment Assignment with Balancing for Prognostic Factors in the Controlled Clinical Trial

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Intravenous itraconazole for prophylaxis of systemic fungal infections in patients with acute myelogenous leukemia and high-risk myelodysplastic syndrome undergoing induction chemotherapy

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Itraconazole prevents invasive fungal infections in neutropenic patients treated for hematologic malignancies: evidence from a meta-analysis of 3,597 patients

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Comparison of caspofungin and amphotericin B for invasive candidiasis

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Breakthrough trichosporonosis in a bone marrow transplant recipient receiving caspofungin acetate

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

Congestive heart failure associated with itraconazole

28 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1346781

28 October 2018

1 reference

https://pubmed.ncbi.nlm.nih.gov/16377679

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Systemic antifungal prophylaxis reduces invasive fungal in acute myelogenous leukemia: a retrospective review of 833 episodes of neutropenia in 322 adults

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/16377679

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1128/AAC.50.1.143-147.2006

1 reference

1 August 2017

1 reference

1 August 2017

1 reference